↓ Skip to main content

Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study

Overview of attention for article published in Rheumatology International, July 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
28 Mendeley
Title
Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study
Published in
Rheumatology International, July 2010
DOI 10.1007/s00296-010-1573-4
Pubmed ID
Authors

Bahar Artım Esen, Gülden Yılmaz, Sami Uzun, Melda Özdamar, Alper Aksözek, Sevil Kamalı, Salih Türkoğlu, Ahmet Gül, Lale Öcal, Orhan Aral, Murat İnanç

Abstract

Previous studies showed a link between systemic lupus erythematosus (SLE) and Epstein-Barr virus (EBV) infection. We sought to determine the features of serologic response to EBV in SLE patients and whether this response differs from those of systemic sclerosis (SSc) and primary antiphospholipid syndrome (PAPS) patients as well as healthy individuals. Sera from 198 consecutive SLE patients have been tested to detect IgG antibodies to EA/D, EBNA-1, VCA P18 and for comparison, cytomegalovirus (CMV) using commercially available ELISA kits (Trinity Biotech, USA). Forty-six SSc patients and 38 PAPS patients were enrolled as diseased control groups and sixty-five individuals as healthy controls. Significantly more SLE (54%, P = 0.001, OR 5.77, 95% CI 2.8-11.6), SSc (41.3%, P = 0.005, OR 3.4, 95% CI 1.4-8.2) and PAPS sera (36.8%, P = 0.023, OR 2.86, 95% CI 1.14-7.22) reacted against EA/D than healthy controls (16.9%). The mean age of anti-EA/D-positive SLE patients was significantly higher, and their disease duration was longer compared to anti-EA/D-negative SLE patients (41 ± 14 vs. 33.8 ± 10.8 years, P < 0.001 and 100 ± 73 vs. 71 ± 62 months, P = 0.003). In SLE patients, EA/D reactivity was associated with Raynaud's phenomenon and the presence of any anti-ENA antibodies. Although it did not reach a statistical significance, anti-EBNA-1 reactivity was slightly lower in patients with SLE. The frequency of anti-CMV Ig G positivity was found significantly higher in SLE patients (100%) when compared to patients with SSc (95.7%), PAPS (94.7%) and healthy controls (95.4%) (P = 0.035, P = 0.025 and P = 0.015 respectively). Our results support the proposed link between EBV and SLE. The finding that SSc and PAPS patients also have increased frequency of anti-EA/D response has revealed that this immune interaction may not be unique to patients with SLE, and there may be a common mechanism involving EBV in these autoimmune diseases.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
United States 1 4%
Netherlands 1 4%
Unknown 25 89%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 18%
Researcher 5 18%
Student > Bachelor 5 18%
Student > Master 3 11%
Professor 2 7%
Other 8 29%
Readers by discipline Count As %
Medicine and Dentistry 10 36%
Agricultural and Biological Sciences 6 21%
Unspecified 5 18%
Immunology and Microbiology 4 14%
Psychology 1 4%
Other 2 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2014.
All research outputs
#2,586,657
of 9,633,164 outputs
Outputs from Rheumatology International
#227
of 963 outputs
Outputs of similar age
#34,033
of 100,397 outputs
Outputs of similar age from Rheumatology International
#2
of 8 outputs
Altmetric has tracked 9,633,164 research outputs across all sources so far. This one has received more attention than most of these and is in the 57th percentile.
So far Altmetric has tracked 963 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 100,397 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.